Vaxcyte, Inc.
PCVXNASDAQHealthcare● Active
$46.33
$-1.03(-2.17%)
Market Cap$6.7B
P/E Ratio—
52W High$65
52W Low$29.08
Vaxcyte, Inc.（PCVX）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PCVX · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $1.56B | $1.75B | $1.08B | $0.93B | $0.25B |
| Net Receivables | $0.05B | $0.02B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $1.63B | $1.79B | $1.10B | $0.94B | $0.26B |
| PP&E Net | $0.49B | $0.27B | $0.11B | $0.03B | $0.04B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $3.05B | $3.51B | $1.41B | $1.01B | $0.32B |
| Liabilities | |||||
| Short-Term Debt | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.07B | $0.05B | $0.01B | $0.01B | $0.01B |
| Total Current Liabilities | $0.21B | $0.14B | $0.15B | $0.04B | $0.03B |
| Long-Term Debt | $0.11B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.36B | $0.21B | $0.17B | $0.05B | $0.04B |
| Stockholders Equity | |||||
| Retained Earnings | ($2.15B) | ($1.39B) | ($0.92B) | ($0.52B) | ($0.30B) |
| Total Stockholders Equity | $2.69B | $3.31B | $1.24B | $0.95B | $0.28B |
| Total Liab & Equity(computed) | $3.05B | $3.51B | $1.41B | $1.01B | $0.32B |
| Debt Summary | |||||
| Total Debt | $0.23B | $0.07B | $0.03B | $0.02B | $0.02B |
| Net Debt | $0.05B | ($0.32B) | ($0.37B) | ($0.82B) | ($0.05B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Vaxcyte, Inc.
关于Vaxcyte, Inc.（PCVX）资产负债表
Vaxcyte, Inc.总资产$3.05B，现金及短期投资$1.56B，总负债$0.36B，总债务$0.23B，股东权益$2.69B。
常见问题
PCVX · 4 问Vaxcyte, Inc.总债务$0.23B，净债务$0.05B。
PCVX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10